影响亚洲不育女性血清抗苗勒管激素水平分布的因素:一项多国、多中心、多民族前瞻性队列研究
该多国多中心前瞻性队列研究纳入4556例20-43岁亚洲不育女性,发现年龄、民族、肥胖(BMI≥30 kg/m²)、多囊卵巢综合征(PCOS)及子宫内膜异位囊肿切除史显著影响血清抗苗勒管激素(AMH)水平,AMH随年龄增长加速下降,4.0 ng/ml为诊断PCOS的最佳截断值。
要点
- 年龄、民族、肥胖(BMI≥30 kg/m²)、PCOS及子宫内膜异位囊肿切除史与血清AMH显著相关。
- AMH随年龄增长而下降,25-33岁年均下降约0.13 ng/ml,33-43岁年均下降0.31 ng/ml。
- AMH 4.0 ng/ml诊断PCOS的敏感度71.7%、特异度75.8%(AUC=0.81,95%CI 0.79-0.83;P<0.001)。
核心结论
- 年龄、民族、肥胖(BMI≥30 kg/m²)和PCOS显著影响亚洲不育女性血清AMH水平,且AMH下降速率随年龄增长而加速。
- 4.0 ng/ml为诊断PCOS的最佳AMH截断值。
研究设计与样本
- 研究类型为基于人群的多国、多中心、多民族前瞻性队列研究,于2020年1月至2021年5月开展。
- 共纳入4613例20-43岁亚洲不育女性,最终分析4556例。
- 参与者来自亚洲12个IVF中心的中国人、日本人、韩国人、泰国人、越南人、马来人、印度人和印度尼西亚人等民族,均为未接受过卵巢刺激周期的女性。
- 排除标准包括年龄<20或>43岁、非亚洲民族及关键数据缺失。
- AMH测定采用临床验证平台上的AMH自动化检测。
主要发现
- 血清AMH浓度(ng/ml)均值±标准差:总体3.44±2.93;<30岁4.58±3.16;30-31岁4.23±3.23;32-33岁3.90±3.06;34-35岁3.21±2.65;36-37岁2.74±2.44;38-39岁2.30±1.91;40岁及以上1.67±2.00。
- AMH下降速率:25-33岁患者约0.13 ng/ml/年,33-43岁女性0.31 ng/ml/年。
- PCOS发生率最高的民族为印度人(18.6%)、马来人(18.9%)和越南人(17.7%)。
- 年龄(P<0.001)、民族(P<0.001)、肥胖(P=0.007)、PCOS(P<0.001)及子宫内膜异位囊肿切除史(P=0.01)与血清AMH值显著相关。
- 吸烟状态、预处理使用GnRH激动剂(GnRHa)或口服避孕药(OCP)、血样冻融及月经周期第2-5天或随机采样似乎不影响血清AMH水平。
关键数值与推荐
- AMH 4.0 ng/ml诊断PCOS的敏感度为71.7%,特异度为75.8%(AUC=0.81,95%CI:0.79-0.83;P<0.001)。
- 年龄<30岁组血清AMH均值±标准差为4.58±3.16 ng/ml。
- 30-31岁组血清AMH均值±标准差为4.23±3.23 ng/ml。
- 32-33岁组血清AMH均值±标准差为3.90±3.06 ng/ml。
- 34-35岁组血清AMH均值±标准差为3.21±2.65 ng/ml。
临床怎么用
- 研究结果表明,本研究所建立的年龄特异性血清AMH参考范围可协助临床医生对亚洲女性的卵巢储备和生殖潜能进行咨询与预后评估。
- 作者认为,这些发现有助于为个性化生育干预提供更好的策略。
- 原文未据此给出推荐。
局限性
- 该队列中PCOS发生率可能偏高,因部分IVF诊所是管理PCOS女性特定生育问题的三级转诊中心。
- AMH检测前接受GnRHa或OCP治疗存在地区和民族局限,主要在香港特别行政区和日本。
- 血清AMH参考值仅限于所研究的亚洲民族女性,可能不适用于未纳入研究的其他民族。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: How do age, ethnicity, and other characteristics affect serum anti-mullerian hormone (AMH) levels in Asian women undergoing fertility treatment? SUMMARY ANSWER: Age, ethnicity, obesity (BMI ≥ 30 kg/m2), and polycystic ovarian syndrome (PCOS) significantly impacted serum AMH levels, with the rate of decrease accelerating as age increased; a concentration of 4.0 ng/ml was the optimal cut-off for diagnosis of PCOS. WHAT IS KNOWN ALREADY: There are significant differences in ovarian reserve among women from different races and ethnicities, and Asian women often have poorer reproductive outcomes during assisted reproductive treatment cycles. STUDY DESIGN, SIZE, DURATION: A population-based multi-nation, multi-centre, multi-ethnicity prospective cohort study of 4613 women was conducted from January 2020 to May 2021. Infertile women of 20-43 years of age were enrolled. The exclusion criteria included: age <20 or >43, non-Asian ethnicity, and missing critical data. PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants were Asian women of Chinese, Japanese, Korean, Thai, Vietnamese, Malay, Indian, and Indonesian ethnicities from 12 IVF centres across Asia. These women were all naïve to ovarian stimulation cycles and attended IVF centres for fertility assessment. The AMH measurement was performed using an AMH automated assay on a clinically validated platform. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 4556 infertile Asian women were included in the final analyses. The mean ± SD for serum AMH concentrations (ng/ml) across specific age groups were: overall, 3.44 ± 2.93; age <30, 4.58 ± 3.16; 30-31, 4.23 ± 3.23; 32-33, 3.90 ± 3.06; 34-35, 3.21 ± 2.65; 36-37, 2.74 ± 2.44; 38-39, 2.30 ± 1.91; 40 and above, 1.67 ± 2.00. The rate of AMH decrease was ∼0.13 ng/ml/year in patients aged 25-33 and 0.31 ng/ml/year in women aged 33-43. The highest rates of PCOS were found in Indians (18.6%), Malays (18.9%), and Vietnamese (17.7%). Age (P < 0.001), ethnicity (P < 0.001), obesity (P = 0.007), PCOS (P < 0.001), and a history of endometrioma cystectomy (P = 0.01) were significantly associated with serum AMH values. Smoking status, pretreatment with GnRH agonist (GnRHa) or the oral contraceptive pill (OCP), freezing-thawing of blood samples, and sampling on Day 2 to Day 5 of the menstrual cycle or randomly did not appear to affect serum AMH levels. An AMH concentration of 4.0 ng/ml was the optimal cut-off for PCOS diagnosis with a sensitivity of 71.7% and specificity of 75.8% (AUC = 0.81, CI 95%: 0.79-0.83; P < 0.001). LIMITATIONS, REASONS FOR CAUTION: The incidence of PCOS was supposedly high in this cohort as some IVF clinics were tertiary referral centres for managing specific fertility issues encountered by women with PCOS. Treatment with GnRHa or OCP before AMH testing was regionally and ethnically confined, mostly in Hong Kong SAR and Japan. Moreover, this reference for serum AMH value is limited to Asian women of the ethnicities examined and may not apply to other ethnicities not included in the study. WIDER IMPLICATIONS OF THE FINDINGS: This is the first study to collate and construct age-specific reference ranges for serum AMH levels using the same bioassay on Asian women of different ethnicities. The findings of this investigation can assist clinicians to counsel and prognosticate about Asian women's ovarian reserve and reproductive potential, thus providing better strategies for personalized fertility interventions. STUDY FUNDING/COMPETING INTEREST(S): This study was technically supported by Ferring Pharmaceuticals and received no specific grant from any funding agency. All authors have no competing interests to disclose. TRIAL REGISTRATION NUMBER: NCT04203355.
引用
- Tzeng CR, Huang Z, Asada Y, et al. Factors affecting the distribution of serum anti-müllerian hormone levels among infertile Asian women: a multi-nation, multi-centre, and multi-ethnicity prospective cohort study. Hum Reprod. 2023. PMID: 37105234. doi:10.1093/humrep/dead081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。